INTRODUCTION
============

Asthma is the most common chronic respiratory disease in children. Global Initiative for Asthma (GINA) guideline had classified level of asthma control according to clinical symptoms into controlled, partly controlled and uncontrolled asthma \[[@B1]\]. Poor control in childhood asthma was associated with numerous consequences; increased medical expense \[[@B2]\], increase exacerbation \[[@B3]\], and decrease quality of life \[[@B4]\]. Consequently, evaluation of level of asthma symptom control and finding the predictor to identify patient who is at risk for subsequent loss of asthma control are considered to be crucial. Pediatric patients may have difficulties in explaining their symptoms or may have poor perception for the change of their respiratory status \[[@B5]\]. Objective measurement including spirometry and exhaled nitric oxide levels may not be an accurate prediction for loss of asthma control \[[@B6][@B7]\].

Forced oscillator technique (FOT) is a noninvasive objective measurement of lung physiology. FOT is a simple, noninvasive method requiring only passive patient cooperation and possibly be a useful tool for pulmonary function assessment in patients especially children who cannot perform acceptable spirometry maneuver \[[@B8][@B9]\]. The parameters measured by FOT consist of resistance (Rrs), reactance (Xrs), and area of reactance (ALX). Rrs at 5 Hz (R5) represents the obstruction in the small and large airways airway while Rrs at 20 Hz (R20) reflects the obstruction of the large airways. Xrs at 5 Hz (X5) is a representative of the elastic and inertial properties of the lungs \[[@B10]\]. A previous study with FOT revealed that the value of R5 could effectively predict asthma exacerbation in children \[[@B11]\]. Bronchodilator response was shown to be a marker of poor asthma control in adolescent and adult asthmatic patients \[[@B12][@B13]\]. The higher bronchodilator response as a risk factor for exacerbations was also documented in a recent GINA guideline \[[@B1]\]. We hypothesized that FOT parameters and their bronchodilator response may have a role in prediction of the future loss of asthma symptom control in clinically well-controlled asthmatic children.

MATERIALS AND METHODS
=====================

Asthmatic children aged 6--12 years, followed-up at least 12 months at Pediatric Allergy Clinic, Ramathibodi Hospital were recruited. Asthma diagnosis was done by pediatric allergist according to GINA guideline as follow (1) recurrence of clinical of airflow limitation including wheezing, cough or difficult breathing and (2) these clinical symptoms were responded well to bronchodilator therapy or inhaled corticosteroid assessing by the improvement of forced expiratory volume in 1 second (FEV~1~) more than 12% or improvement of clinical symptoms in case that spirometry could not be performed. All enrolled children were prescribed inhaled corticosteroids. Children evaluated having well-controlled asthma according to GINA were enrolled. Children who had chronic pulmonary disease other than asthma, cardiovascular disease, history of smoking, lower respiratory tract infection in the past 4 weeks, or unable to performed spirometer or FOT were excluded. Written informed consents were obtained from children and their guardians. The study protocol was approved by the ethic committee of Faculty of Medicine, Ramathibodi Hospital, Mahidol University (ID 01-59-06).

Study protocol
--------------

Two visits of evaluation in 12 weeks interval were performed. At the first visit, history of diagnosis of asthma, step of asthma treatment, and evidence of aeroallergen sensitization were reviewed. Asthmatic symptoms were assessed. FOT and spirometer, pre- and postbronchodilator with 400 μg of salbutamol inhalation were evaluated in the first visits. Percentage of bronchodilator response (%∆) was calculated from the difference absolute value obtained before and after salbutamol inhalation then divided by the absolute values before salbutamol and the result was multiplied by 100. Because of the possible effects of forced expiratory maneuvers on the bronchial motor tonus \[[@B14]\], first FOT and then spirometry was performed. FOT, using MostGraph-01 (Chest M.I., Co. Ltd., Tokyo, Japan), was performed according to European Respiratory Society criteria \[[@B15]\]. FOT was performed during spontaneous tidal breathing. During data acquisition, pressure and flow traces were graphically displayed in real time. Measurements were accepted when the tracings showed uninterrupted breathing during data acquisition. Measurements were rejected if disturbed by coughing, breath holding, swallowing, or vocalization. Measurement Parameters including R5, R20, and X5, were measured. The spirometry, using Spiromaster PC-10 (Chest M.I., Co. Ltd.), was then performed. Forced vital capacity (FVC), FEV~1~, FEV~1~/FVC ratio, and forced expiratory flow at 25%--75% of FVC (FEF~25%--75%~) were measured. At the end of study, the children who still had well-controlled asthma as GINA were identified as "maintained-controlled group" (C-C group). The children who did not meet the criteria of well-controlled asthma were classified as "lost-controlled group" (C-LC group).

Statistical analysis
--------------------

R ver. 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria) and IBM SPSS ver. 18.0 (IBM Co., Armonk, NY, USA) were used for statistical analysis. Comparison of baseline characteristics was performed by chi-square test or *t* test and Fisher exact test or Wilcoxon rank sum test in normal and nonnormal distribution respectively. Difference of parameters of FOT and spirometer in 2 groups was detected by *t* test and Wilcoxon rank-sum test. Pearson correlation coefficient was used to establish associations between parameters. The receiver operating characteristic (ROC) method and area under the curve (AUC) were used to estimate the optimal cutoff point of parameters of FOT to predict lost-controlled status. Multivariate stepwise logistic regression analysis was performed to identify the independent predictive factors for lost-asthma control status. All variables were added to the model/prediction and non-significant variables were removed.

RESULTS
=======

Sixty-eight well-controlled asthmatic children were enrolled to the study: 45 children (66.2%) were male. The mean age was 9.5 years. At 12-week follow-up, 41 subjects (60.3%) were stable at their well-controlled level (C-C group) while 27 of them (39.7%) were identified having loss of asthma symptom control (C-LC group). Sex, weight, aeroallergen sensitization status, incidence of allergic rhinitis, history of environmental tobacco smoke exposure, age of asthma diagnosis, duration of asthma, and the dosage of inhaled corticosteroid were not significantly different between the 2 groups. However, the subjects in C-LC group were statistically younger and shorter (*P*\<0.005) ([Table 1](#T1){ref-type="table"}).

###### Baseline characteristics

![](apa-10-e3-i001)

  Variable                                 C-C group (n = 41)   C-LC group (n = 27)   *p* value
  ---------------------------------------- -------------------- --------------------- -----------
  Sex                                                                                 0.74
                                           Male                 26 (63.4)             19 (70.4)
                                           Female               15 (36.6)             8 (29.6)
  Age (yr)                                 9.93 ± 1.85          8.93 ± 2.0            0.04
  Height (cm)                              137.07 ± 13.44       128.37 ± 13.45        0.01
  Weight (kg)                              37.59 ± 13.99        31.78 ± 13.81         0.10
  Aeroallergen sensitization               31 (75.6)            22 (81.5)             0.79
  Allergic rhinitis                        3 (85.4)             22 (81.5)             0.81
  Tobacco exposure                         8 (19.5)             5 (18.5)              0.08
  Age of asthma diagnosis (yr)             5.83 ± 2.71          4.96 ± 2.02           0.16
  Duration of asthma (yr)                  3.86 ± 2.13          3.71 ± 1.99           0.77
  Inhaled corticosteroid dosage (µg)^\*^   218.79 ± 185.15      203 ± 140.72          0.95

Values are presented as number (%) or mean ± standard deviation.

C-C group, group of children who maintained their level of asthma well-controlled; C-LC group, group of children who lost their level of asthma well-controlled at the end of the study.

^\*^Beclomethasone equivalent dose/day.

Comparison of FOT parameters
----------------------------

The comparison of FOT parameters between the 2 groups was showed in [Table 2](#T2){ref-type="table"}. The value of R5, R20, X5, and ALX in C-C group were significantly lower than C-LC group. However, only %predicted of R5 was significantly difference between C-C and C-LC groups. The percentage of bronchodilator response (%∆) in the following parameters: R5 and R20 in C-LC group were significantly higher than those in C-C group ([Table 2](#T2){ref-type="table"}).

###### Comparison forced oscillation technique measures between C-C and C-LC groups
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  Variable                  C-C group             C-LC group       *p* value        
  ------------------------- --------------------- ---------------- ---------------- ---------
  Prebronchodilator                                                                 
                            R5 (cmH~2~O/L/sec)    6.98 ± 2.11      9.98 ± 2.42      \<0.001
                            R5 (% predicted)      89.28 ± 18.44    114.91 ± 23.39   \<0.001
                            R20 (cmH~2~O/L/sec)   5.83 ± 1.52      7.82 ± 1.61      \<0.001
                            R20 (% predicted)     118.84 ± 38.85   126.56 ± 34.27   0.405
                            X5 (cmH~2~O/L/sec)    −0.63 ± 0.47     −0.93 ± 0.61     0.03
                            X5 (% predicted)      27.95 ± 21.70    27.46 ± 20.53    0.9
                            ALX                   2.54 ± 2.22      4.19 ± 4.04      0.03
  Bronchodilator response                                                           
                            ∆R5 (%)               12.92 ± 10.48    30.28 ± 11.32    \<0.001
                            ∆R20 (%)              13.96 ± 10.4     24.65 ± 11.52    \<0.001
                            ∆ALX (%)              14.58 ± 62.45    26.43 ± 64.4     0.45

Values are presented as mean ± standard deviation.

C-C group, group of children who maintained their level of asthma well-controlled; C-LC group, group of children who lost their level of asthma well-controlled at the end of the study.

R5, resistance at 5 Hz; R20, respiratory resistance at 20 Hz; X5, respiratory reactance at 5 Hz; ALX, area of reactance; ∆, percentage of bronchodilator response.

Comparison of spirometric parameters
------------------------------------

The comparison of spirometric measurement was presented in [Table 3](#T3){ref-type="table"}. There is no significant difference in all spirometric measurement between C-C and C-CL groups. The percentage of bronchodilator response (%∆) in the following parameters: FVC, FEV~1~, and FEF~25%--75%~ in C-LC group were statistically significant higher than in C-C group ([Table 3](#T3){ref-type="table"}).

###### Comparison spirometric measures between C-C and C-LC groups
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  Variable                  C-C group                     C-LC group    *p* value     
  ------------------------- ----------------------------- ------------- ------------- -------
  Prebronchodilator                                                                   
                            FVC (% predicted)             92.5 ± 10.0   98.7 ± 16.6   0.06
                            FEV~1~ (% predicted)          89.7 ± 13.3   96 ± 19.4     0.11
                            FEV~1~/FVC (%)                88.5 ± 6.6    87.6 ± 5.5    0.58
                            FEF~25%--75%~ (% predicted)   95 ± 29.3     92.3 ± 29.3   0.71
  Bronchodilator response                                                             
                            ∆FVC (%)                      1.3 ± 5.9     4.3 ± 4.5     0.03
                            ∆FEV~1~ (%)                   3.7 ± 5.9     7.9 ± 5.4     0.004
                            ∆FEV~1~/FVC (%)               2.4 ± 3.4     3.5 ± 3.4     0.18
                            ∆FEF~25%--75%~(%)             15.1 ± 15.4   23.3 ± 15.9   0.04

Values are presented as mean ± standard deviation.

C-C group, group of children who maintained their level of asthma well-controlled; C-LC group, group of children who lost their level of asthma well-controlled at the end of the study.

FVC, forced vital capacity; FEV~1~, forced expiratory volume in 1 second; FEF~25%-75%~, forced expiratory flow 25%--75%; ∆, percentage of bronchodilator response.

Loss of asthma symptom control predictors
-----------------------------------------

To find the independent predictive factors for predicting future loss of asthma symptom control in previously well-controlled subjects. Multivariate ordered logistic regression analysis was demonstrated that %predicted of R5, %∆ R5, %predicted of FEV~1~, and %∆ FEV~1~ were the significant predictive factors for predicting future of asthma control ([Table 4](#T4){ref-type="table"}). ROC was calculated to make an optimal cutoff point for predicting the loss of asthma control. The %predicted of R5 at 91.28 predicts the future loss of asthma with a sensitivity of 82% and a specificity of 56% (AUC = 0.8; *p* \< 0.001). The %∆R5 of 21.2% predicts the future loss of asthma with a sensitivity of 70% and a specificity of 70% (AUC = 0.79; *p* \< 0.001). The %∆FEV~1~ of 7.8% predicts the future loss of asthma with a sensitivity of 52% and a specificity of 76% (AUC = 0.69; *p* \< 0.008) and %predicted of FEV~1~ of 89.5% predicts the future loss of asthma with a sensitivity of 52% and a specificity of 52% (AUC = 0.54; *p* = 0.55) ([Table 5](#T5){ref-type="table"}). The combination of these parameters demonstrated the best regression coefficients with AUC (0.924; *p* \< 0.001) and the accuracy of 83.8%. The predictive equation is regression coefficients = -15.308 + 0.059%predicted of FEV~1~ 0.177 + 0.302%∆FEV~1~ + 0.045%predicted of R5 + 0.144%∆R5.

###### Logistic regression to predict loss of asthma control
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  Predictor variable     Regression coefficient   AUC (95% CI)           *p* value
  ---------------------- ------------------------ ---------------------- -----------
  R5 (% predicted)       0.059                    0.810 (0.700--0.920)   \<0.001
  R5 (% predicted)       0.049                    0.859 (0.770--0.950)   \<0.001
  ∆R5 (%)                0.069                    \-                     \-
  ∆FEV~1~ (%)            0.278                    0.910 (0.840--0.980)   \<0.001
  R5 (% predicted)       0.044                    \-                     \-
  ∆R5 (%)                0.124                    \-                     \-
  FEV~1~ (% predicted)   0.059                    0.924 (0.860--0.990)   \<0.001
  ∆FEV~1~ (%)            0.302                    \-                     \-
  R5 (% predicted)       0.045                    \-                     \-
  ∆R5 (%)                0.144                    \-                     \-

AUC, area under the curve; CI, confidence interval; R5, resistance at 5 Hz; FEV~1~, forced expiratory volume in 1 second.

###### Cutoff points in predicting of loss of asthma symptom control on a follow-up visit
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  Variable                      Cutoff points                 AUC (95% CI)   Sensitivity            Specificity   *p* value   
  ----------------------------- ----------------------------- -------------- ---------------------- ------------- ----------- ---------
  FOT parameters                                                                                                              
                                R5 (% predicted)              91.28          0.812 (0.702--0.922)   0.821         0.56        \<0.001
                                R20 (% predicted)             122.23         0.55 (0.41--0.69)      0.59          0.52        0.48
                                X5 (% predicted)              21.16          0.47 (0.33--0.61)      0.48          0.44        0.72
  Spirometric parameters                                                                                                      
                                FVC (% predicted)             96.4           0.60 (0.44--0.75)      0.52          0.66        0.176
                                FEV~1~ (% predicted)          89.5           0.54 (0.387--0.699)    0.52          0.52        0.55
                                FEV~1~/FVC (%)                88.99          0.43 (0.29--0.57)      0.52          0.44        0.32
                                FEF~25%--75%~ (% predicted)   91.65          0.46 (0.32--0.60)      0.48          0.59        0.57
  Postbronchodilator response                                                                                                 
                                ∆R5 (%)                       21.2           0.79 (0.68--0.90)      0.70          0.70        \<0.001
                                ∆R20 (%)                      24.8           0.74 (0.62--0.86)      0.52          0.90        \<0.001
                                ∆FVC (%)                      2.75           0.67 (0.54--0.80)      0.70          0.59        0.018
                                ∆FEV~1~ (%)                   7.8            0.69 (0.57--0.81)      0.52          0.76        0.008
                                ∆FEV~1~/FVC (%)               3              0.59 (0.45--0.72)      0.52          0.63        0.21
                                ∆FEF~25%--75%~(%)             15.2           0.65 (0.52--0.79)      0.70          0.57        0.035

FOT, forced oscillation technique; AUC, area under the curve; CI, confidence interval; R5, resistance at 5 Hz; R20, respiratory resistance at 20 Hz; X5, respiratory reactance at 5 Hz; FVC, forced vital capacity; FEV~1~, forced expiratory volume in 1 second; FEF~25%-75%~, forced expiratory flow 25%--75%; ∆, percentage of bronchodilator response.

DISCUSSION
==========

Our study demonstrates that 40% of asthmatic children who had well-controlled asthma according to GINA lost their asthma symptom control in the next 12 weeks. Significant difference in baseline FOT measures between children who maintained their level of controlled asthma and those who lost their asthma level of control were demonstrated but there were no significant differences in spirometric measures between the 2 groups. FOT measures were shown to have more clinical value in distinguishing asthmatics from nonasthma children than spirometric measures \[[@B16][@B17]\]. Marotta et al. \[[@B16]\] have shown that percentage of bronchodilator response of resistance FOT measures were different between children who have asthma and those who did not have asthma while spirometric parameters were not different between the 2 groups. Similar result was also demonstrated in Korean asthmatic children \[[@B17]\]. However, studies in adolescent and adult asthmatic and healthy subjects have shown the equality informative of resistance FOT measures and spirometry measures for asthma diagnosis and as a potential marker of asthma control \[[@B18][@B19]\]. FOT measurement was suggested to be more sensitive than spirometry in detecting subtle changes of lung function in children \[[@B20]\].

Spirometric parameters especially FEV~1~ was proposed to be a predictor for asthma exacerbation. Low FEV~1~ especially less than 60%predicted is a strong predictor of asthma exacerbation \[[@B21]\]. In the present study, we found that FEV~1~ alone might not be good enough to predict future loss of asthma control in clinically well-controlled asthmatic children and all of our enrolled children had FEV~1~ more than 60%predicted. We have proposed the following cutoff values for predicting future loss of asthma control: % predicted of R5 = 91.28 (AUC = 0.81), %R5 = 21.1 (AUC = 0.79) and %∆ FEV~1~=7.8 (AUC = 0.69). We also have demonstrated that combination between FOT measured resistance at 5 Hz and FEV~1~ provided the best AUC and accuracy for predicting future loss of asthma control in well control asthmatic children. These findings would highlight the ability of using FOT resistance measure as a predictor for loss of asthma control.

Even though, we found the significant differences in all FOT measures between children who could maintain their asthma clinical controlled and those who lost control of asthma. From logistic regression analysis adjusted for all parameters which were significant differences between controlled and lost-controlled groups, only %predicted of R5, %∆ R5, %predicted of FEV~1~, and %∆FEV~1~ showed significantly associated with the status of asthma control at 12 weeks. This result can be explained form the high association between R5 and R20.

In the present study, there was no significant differences in baseline spirometric parameter between children who could maintain their level of asthma control and those who lost their asthma control. However, percentage of bronchodilator response of FEV~1%~ and FVC % were significant higher in those who lost of their asthma control. These results were consistent with a recent study in children and adolescents which shown that FEV~1~ bronchodilator response is better than FEV~1%~predicted in distinguishing difficult-to-control from easy-to-control asthma \[[@B22]\]. As a result, higher FEV~1~ bronchodilator response should be one of the predictor for future loss of asthma control especially in children with normal FEV~1~. We have purposed to use the cutoff value for postbrochodilator response (%∆) of FEV~1~ = 7.8% as a prediction for future of loss of asthma control. However, %∆FEV~1~ has less sensitivity and specificity in predicting loss of asthma control than %∆R5.

FOT measures were associated with height and age \[[@B15]\]. In the present study, there were significant differences in age and height of children who could maintain their asthma control (C-C) and those who lost their asthma control (C-CL). These differences should have effects on FOT measures. However, after the stepwise multiple logistic regression analysis, age and height were eliminated from the model. As a result, the differences in age and height in C-C and C-CL should not have significant effect on the analysis of the present study.

To the best of our knowledge, our study is the first prospective study using the percentage of bronchodilator response of FOT measures in predicting loss of control in asthmatic children. No patient was reported as lost to follow-up. However, our study still has some limitation. First, this study is the preliminary study in a small number of asthmatic children. The result may not be able to generalize to all asthmatic children. Further study with a larger sample size is required to confirm the usefulness of FOT measure in prediction future loss of asthma control. Second, the longer follow-up period might be required to observe the symptoms of future loss of control in the patients who remained controlled at 12-week visit.

In conclusion, we have shown that baseline FOT measured resistance at 5 Hz and its percentage of bronchodilator response were the better predictor for the future of loss of asthma control in those previously well control than spirometric measures. However, the combination with spirometric measure increased the accuracy as demonstrated by AUC in a logistic regression model. While standard spirometric parameters cannot well distinguish asthmatic children who will lost their asthma control from those who can maintain asthma well control. FOT parameters could play an additive role in predicting loss of control in the subsequent 12 weeks with a high predictive value.
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